HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Holmium laser enucleation of the prostate: initial report of the first 230 Egyptian cases performed in a single center.

AbstractOBJECTIVES:
To report our experience with the first 230 cases of holmium laser enucleation of the prostate (HoLEP) performed in a single center.
METHODS:
A total of 230 cases of HoLEP were performed between June 2007 and June 2008. Mean age of patients was 69.8 +/- 10.3 years, and 21.3% of patients were either on anticoagulant or antiplatelet treatment. There was no limit for prostate size, with a mean prostate size of 86.5 +/- 65.4 g (range: 20-350 g). Follow-up was performed regularly at 1, 3, 6, and 12 months, assessing the Q(max), PVR, and International Prostate Symptom Score.
RESULTS:
Weight of prostate chips retrieved after morcellation was 78.6 +/- 61.3 g (range: 10-350), with enucleation time 102.2 +/- 55.4 minutes and morcellation time 19.3 +/- 10.1 minutes, leading an estimated efficiency rate of 0.64 g/min. The rate of decrease in prostate volume and prostate-specific antigen was 90.8% and 82.5%, respectively. At 1 month, mean Q(max) increased from 7.7 +/- 2.3 to 25.8 +/- 10.1 mL/s (P <or=.001), mean PVR decreased from 171.3 +/- 126.3 to 41.6 +/- 45.7 mL (P <or=.001), and mean international prostate symptom score improved from 17.3 +/- 6.7 to 6.6 +/- 3.4 (P <or=.001). These improvements were sustained throughout a 12-month follow-up period. Temporary irritative symptoms were evident in 34.6% and stress urinary incontinence in 9%, both of which were self-limited on medical treatment and Kegel exercises, respectively. Only 1 patient with pancytopenia required blood transfusion and there was no case for transurethral resection syndrome.
CONCLUSIONS:
HoLEP is a safe and an effective modern modality for the treatment of symptomatic BPH regardless of the gland size, with satisfactory clinical outcome.
AuthorsAmr M Abdel-Hakim, Enmar I Habib, Ahmed S El-Feel, Ahmed G Elbaz, Amr M Fayad, Mahmoud A Abdel-Hakim, Alaa W Meshref
JournalUrology (Urology) Vol. 76 Issue 2 Pg. 448-52 (Aug 2010) ISSN: 1527-9995 [Electronic] United States
PMID20223507 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Egypt
  • Follow-Up Studies
  • Humans
  • Lasers, Solid-State (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Prostatectomy (adverse effects, methods)
  • Prostatic Hyperplasia (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: